Saghmos Therapeutics Announces Appointment of FDA Veteran Stephen Grant, MD, as Chief Regulatory Officer

Saghmos Therapeutics, Inc. announced the appointment of Stephen Grant, MD, as Chief Regulatory Officer.

Scroll to Top